|
609 Pharmacists to
have new powers during pandemic New powers
are likely to be given to community pharmacists during an influenza pandemic
to allow them to supply medicines and provide services in a more flexible
manner
PJ 2007;279:609
Full Text
609 Regulation oversight body launches
legal challenge to a Statutory Committee decision A
pharmacist who was reprimanded by the Royal Pharmaceutical Society's
Statutory Committee is to have her case re-examined in the High Court
because the Council for Healthcare Regulatory Excellence believes that
the reprimand was unduly lenient. This is the first time the CHRE has
used its legal powers to challenge a Statutory Committee ruling
PJ 2007;279:609
Full Text
609 Anti-counterfeiting strategy Counterfeit
medicines are the focus of a new three-year strategy developed by the Medicines
and Healthcare products Regulatory Agency
PJ 2007;279:609
Full Text
610 Report highlights little
progress in implementing PBC Redesign of health
care services and their transfer from secondary to primary care has yet to gather
pace under practice-based commissioning, according to an Audit Commission report
published last week
PJ 2007;279:610
Full Text
610 “Virtual” chain for independents launched UniChem has launched a “virtual” chain for independent pharmacies in the UK, providing them with support for professional and business services. Alphega Pharmacy, launched last week in partnership with Alliance Healthcare, is a pan-European chain, with over 800 members in France, Italy and Spain. It is currently being piloted in five UK pharmacies
PJ 2007;279:610
Full Text
610 Abolishing script charges may affect MAS The
Scottish Government remains committed to the minor ailment service (MAS) but
will have to consider what implications abolishing NHS prescription charges will
have on the service, the health secretary has said
PJ 2007;279:610
Full Text
610 Model pharmacy opened at the University
of Nottingham The University of Nottingham’s school of pharmacy is the latest school to open a model pharmacy, allowing students to train in a more realistic environment
PJ 2007;279:610
Full Text
610 Section 60 Order consultation Consultation
has started on a draft Section 60 Order to standardise the workings of the General
Medical Council, the General Optical Council, the General Osteopathic Council,
the General Chiropractic Council and the Nursing and Midwifery Council
PJ 2007;279:610
Full Text
610 Support services for self-care Evidence
showing the effectiveness of support services for self-care has been collected
and published by the Department of Health
PJ 2007;279:610
Full Text
610 PDA union elections Elections to the executive committee that is to run the Pharmacists’ Defence Association Union are about to be held
PJ 2007;279:610
Full Text
611 Global sum is secure,
minister tells Parliament Parliament has been told
that primary care trusts will not be able to raid pharmacy funding when responsibility
for it is transferred from the Department of Health
PJ 2007;279:611
Full Text
611 Pharmacy numbers rise Data
released by the Information Centre show that in March 2007 the number of community
pharmacies in England reached 10,133, a rise of 257, and the total for England
and Wales was 10,839
PJ 2007;279:611
Full Text
611 Premises fee fixed for 2008 Registration fees for pharmacies in Great Britain are to rise by 3.6 per cent to £510 on 1 January 2008. The premises retention fee will rise by 3.8 per cent to £162
PJ 2007;279:611
Full Text
611 Clear direction needed, says health minister The Government’s White Paper on pharmacy must set out a clear direction of travel so that pharmacists can plan, develop and invest with confidence, said health minister Dawn Primarolo, at an All-Party Pharmacy Group meeting this week
PJ 2007;279:611
Full Text
612 Oxfam criticises industry
over access to medicines Oxfam has criticised the
pharmaceutical industry for not putting access to medicines at the heart of its
business models
PJ 2007;279:612
Full Text
612 Pharmacists unaware of lack of standards
for clinical support tools Pharmacists would welcome
training in the use of clinical decision support tools, according to a survey
carried out by independent business consultant Sterling Consultants
PJ 2007;279:612
Full Text
612 Half of patients at risk of secondary MI
stop taking prescribed medicines within three years More
than half of patients suffering a myocardial infarction (MI) stop taking drugs
prescribed to reduce their cardiovascular risk within three years, according
to a US study presented at an American Heart Association meeting held in Orlando,
Florida, last month
PJ 2007;279:612
Full Text
613 Revised estimates put
global HIV at 33.2 million Estimates of the number
of people living with HIV worldwide have been revised downwards. In a report
published last week, the World Health Organization and the United Nations put
the global figure at 33.2 million, down from a previous estimate of 39.5 million.
It says that this substantial reduction is largely due to refinements in methodology,
rather than trends in the pandemic
PJ 2007;279:613
Full Text
613 Around 21,600 people in UK are unaware of
their HIV positive status An estimated 21,600 adults
in the UK are unaware of their HIV positive status, according to the Health Protection
Agency. The figure, released ahead of World AIDS Day on 1 December 2007, makes
up around a third of the 73,000 adults thought to be living with HIV in the UK
PJ 2007;279:613
Full Text
613 Better prophylaxis of maternal HIV transmission
in developing world could limit resistance Tenofovir
and emtricitabine should be considered as an add-on to standard treatment with
nevirapine for preventing transmission of HIV from mother to child in the developing
world, a study suggests
PJ 2007;279:613
Full Text
614 Omalizumab approved for
allergic asthma sufferers People with unstable
allergic asthma could now be eligible to receive omalizumab (Xolair), with the
launch of new guidance by the National Institute for Health and Clinical Excellence
this week
PJ 2007;279:614
Full Text
614 NICE recommends ezetimibe with or without
statin therapy for hypercholesterolaemia Ezetimibe
(Ezetrol) is recommended for the treatment of people with high cholesterol who
cannot take statins in the latest round of guidance from the National Institute
for Health and Clinical Excellence. Ezetimibe can also be used in conjunction
with statin therapy for people whose cholesterol is not adequately controlled
after appropriate dose increases of statin
PJ 2007;279:614
Full Text
614 Nottingham captures hearts Nottingham
City NHS Primary Care Trust is working with the Association of the British Pharmaceutical
Industry to identify people at risk of developing cardiovascular disease
PJ 2007;279:614
Full Text
614 Wales allows use of agalsidase alfa and
oral vinorelbine Agalsidase alfa (Replagal) and
oral vinorelbine (Navelbine Oral) have been recommended for use in the NHS in
Wales
PJ 2007;279:614
Full Text
614 Department of Health advises on immunoglobulin
supply Guidance on managing demand for and maintaining
supply of immunoglobulin has been issued by the Department of Health. The guidance
was developed by a working group of pharmacists, doctors, nurses and commissioners
PJ 2007;279:614
Full Text
615 Leeds needle exchange
services scoop HSJ award Revamped pharmacy needle
exchange services in Leeds took home the prize for patient-centred care at this
year's Health Services Journal awards, presented in London last week
PJ 2007;279:615
Full Text
615 Critical care team recognised by UKCPA Intubation
of critically ill patients using etomidate as the anaesthetic drug does not increase
mortality and etomidate can continue to be used, despite controversial recommendations
from researchers that it should no longer be used in the intensive care setting,
a study suggests
PJ 2007;279:615
Full Text
615 Hospital pharmacy team wins BUPA communication
award A pharmacy team from Darlington has won the
BUPA Foundation's annual communication award presented at a ceremony held last
month at Lincoln's Inn, London
PJ 2007;279:615
Full Text
615 Top UniChem award goes to Wimbledon pharmacist Raj
Patel, an independent pharmacist from Mount Elgon Pharmacy, Wimbledon, was named
this year's overall winner at the UniChem pharmacy awards 2007
PJ 2007;279:615
Full Text |
The
Pharmaceutical Journal